These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2280360)

  • 1. Michaelis-Menten metabolite formation kinetics: equations relating area under the curve and metabolite recovery to the administered dose.
    Chow AT; Jusko WJ
    J Pharm Sci; 1990 Oct; 79(10):902-6. PubMed ID: 2280360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.
    Wagner JG; Szpunar GJ; Ferry JJ
    Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the identification of Michaelis-Menten elimination parameters from a single dose-response curve.
    Godfrey KR; Fitch WR
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):193-221. PubMed ID: 6491901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general model of metabolite kinetics following intravenous and oral administration of the parent drug.
    Weiss M
    Biopharm Drug Dispos; 1988; 9(2):159-76. PubMed ID: 3370305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-pass effect: nonlinear concept comprising an explicit solution of integrated Michaelis-Menten equation.
    Keller F; Scholle J
    J Pharm Sci; 1981 Feb; 70(2):195-8. PubMed ID: 7205226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.
    Cheng HY; Jusko WJ
    Pharm Res; 1988 Mar; 5(3):156-64. PubMed ID: 3244627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.
    Pang KS
    Drug Metab Dispos; 1995 Feb; 23(2):166-77. PubMed ID: 7736907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
    Dadashzadeh S; Tajerzaden H
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs.
    Saganuwan SA
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):57. PubMed ID: 34635182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear theophylline elimination.
    Tang-Liu DD; Williams RL; Riegelman S
    Clin Pharmacol Ther; 1982 Mar; 31(3):358-69. PubMed ID: 7060318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical analysis and drug exposure evaluation of pharmacokinetic models with endogenous production and simultaneous first-order and Michaelis-Menten elimination: the case of single dose.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2018 Oct; 45(5):693-705. PubMed ID: 29987574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic parameter estimation by numerical algorithms and multiple linear regression: application to pharmacokinetics.
    Yeh KC; Kwan KC
    J Pharm Sci; 1979 Sep; 68(9):1120-4. PubMed ID: 501533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The deterministic identifiability of nonlinear pharmacokinetic models.
    Godfrey KR; Fitch WR
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):177-91. PubMed ID: 6491900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1989; 10(5):513-28. PubMed ID: 2804255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a programmable calculator to determine steady-state levels of drugs eliminated by parallel first-order and Michaelis-Menten kinetics.
    Crow JW; Levy G
    Am J Hosp Pharm; 1978 Sep; 35(9):1075-7. PubMed ID: 696752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.
    Wagner JG
    Clin Pharmacokinet; 1985; 10(5):432-42. PubMed ID: 3899457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational problems of compartment models with Michaelis-Menten-type elimination.
    Metzler CM; Tong DD
    J Pharm Sci; 1981 Jul; 70(7):733-7. PubMed ID: 7264916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed form solutions and dominant elimination pathways of simultaneous first-order and Michaelis-Menten kinetics.
    Wu X; Li J; Nekka F
    J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):151-61. PubMed ID: 25678215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probenecid disposition by parallel Michaelis-Menten and dose-dependent pseudo-first-order processes.
    Ho JC; Conway WD; Melethil S
    J Pharm Sci; 1986 Jul; 75(7):664-8. PubMed ID: 3761166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.